Herbal extracts used for upper respiratory tract infections: Are there clinically relevant interactions with the cytochrome P450 enzyme system?

Planta Medica

Volumn 74, Issue 6, 2008, Pages 657-660

  Heinrich, Michael ^a   Modarai, Maryam ^a   Kortenkamp, Andreas ^a  

^a UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Asteraceae; Cytochrome P450; Drug safety; Echinacea; Herb drug interactions; Kan Jang (Andrographis paniculata Eleutherococcus senticosus); Upper respiratory infections

Indexed keywords

ANDROGRAPHIS PANICULATA EXTRACT; ASTRAGALUS MEMBRANACEUS EXTRACT; CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 2C19; CYTOCHROME P450 2C9; CYTOCHROME P450 2D6; CYTOCHROME P450 3A4; DECONGESTIVE AGENT; ECHINACARE; ECHINACEA EXTRACT; ECHINACEA PURPUREA EXTRACT; ECHINAGARD; ELEUTHEROCOCCUS SENTICOSUS EXTRACT; EMOLLIENT AGENT; HERBACEOUS AGENT; IMMUNOMODULATING AGENT; NON PRESCRIPTION DRUG;

ANDROGRAPHIS PANICULATA; COMPETITIVE INHIBITION; CONFERENCE PAPER; DRUG EFFECT; DRUG ISOLATION; DRUG METABOLISM; DRUG SAFETY; ECHINACEA; ECHINACEA PURPUREA; ELEUTHEROCOCCUS SENTICOSUS; ENZYME INHIBITION; HUMAN; IMMUNOMODULATION; IN VITRO STUDY; NONHUMAN; STATISTICAL SIGNIFICANCE; UPPER RESPIRATORY TRACT INFECTION;

ANDROGRAPHIS; ASTRAGALUS PLANT; CYTOCHROME P-450 ENZYME SYSTEM; ECHINACEA; ELEUTHEROCOCCUS; HERB-DRUG INTERACTIONS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; RESPIRATORY TRACT INFECTIONS;

ANDROGRAPHIS; ASTERACEAE; ECHINACEA (ASTERACEAE);

EID: 45349108603     PISSN: 00320943     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1034292     Document Type: Conference Paper

References (18)

1. BfArM. Bewertung möglicher pharmakokinetischer Arzneimittel-In- teraktionen mit Phytopharmaka. 2004. Available at http://www.bfarm.de/cln_042/ nn_424630/DE/Arzneimittel/besTherap/amPnanz/ ampflanz-node.html. Accessed August 20, 2006
2. Williamson EM. Interactions between herbal and conventional medicines. Expert Opin Drug Saf 2005; 4: 1-24
3. Van den Bout-van den Beukel CJP, Koopmans PP. van der Men AJAM, De Smet PAGM, Burger DM. Possible rrug - metabolism interactions of medicinal herbs with antiretroviral agents. Drug Metabol Rev 2006; 38:477-514
4. Barnes J, Anderson LA, Gibbons S, Phillipson JD. Echinacea angustifolia (D.C.) Hell. Echinacea pallida (Nutt.) Nutt., Echinacea purpurea (L.) Moench: a review of their chemistry, pharmacology and clinical properties. J Pharm Pharmacol 2005; 57: 929 - 54
5. Woelkart K, Marth E, Suter A, Schoop R, Raggam RB, Koidl C et al. Bioavailability and pharmacokinetics of Echinacea purpurea preparations and their interactions with the immune system. Int J Clin Pharmacol Ther 2006; 44: 401-8
6. Shah SA, Sander S, White CM, Rinaldi M, Coleman CI. Evaluation of Echinacea for the prevention and treatment of the common cold: a meta-analysis. Lancet Infect Dis 2007; 7: 473 - 80
7. Schoop R, Klein P, Suter A, Johnson SL. Echinacea in the prevention of induced rhinovirus colds: A meta-analysis. Clin Ther 2006; 28: 174-83
8. Budzinski JW, Foster BC, Vandenhoek S, Arnason JT. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000; 7: 273 - 82
9. Yale SH. Glurich I. Analysis of the inhibitory potential of Gingko biloba, Echinacea purpurea, and Serenoa repens on the metabolic activity of cytochrome P450 3A4, 2D6, and 2C9. J Altern Complement Med 2005; 11: 433-9
10. Gorski JC, Huang SM, Pinto A, Hamman MA, Hilligoss JK, Zaheer NA et al. The effect of Echinacea (Echinacea purpurea root) on cytochrome P450 activity in vivo. Clin Pharmacol Ther 2004; 75: 9-100
11. Gurley BI, Gardner SF, Hubbard MA, Williams DK, Gentry WB, Carrier J et al. In vivo assessment of botanical supplementation on human cytochrome P450 phenotypes: Citrus aurantium. Echinacea purpurea, milk thistle and saw palmetto. Clin Pharmacol Ther 2004; 76: 428-40
12. Modarai M, Gertsch J, Suter A, Heinrich M, Kortenkamp A. Cytochrome P450 inhibitory action of Echinacea preparations differs widely and co-varies with alkylamide content. J Pharm Pharmacol 2007; 59: 567-73
13. Matthias A, Gillam EM, Penman KG, Matovic NJ, Bone KM, De Voss JJ et al. Cytochrome P450 enzyme-mediated degradation of Echinacea alkylamides in human liver microsomes. Chem Biol Interact 2005; 155:62-70
14. Helium BH, Hu Z, Nilsen OG. The induction of CYP1A2. CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin Pharmacol Toxicol 2007; 100: 3-30
15. Hovhannisyan AS, Abrahamyan H, Gabrielyan ES, Panossian AG. The effect of Kan Jang extract on the pharmacokinetics and pharmacodynamis of warfarin in rats. Phytomedicine 2006; 13: 318-23
16. Pekthong D, Martin H, Abadie C, Bonet A, Heyd B. Differential inhibition of rat and human hepatic cytochrome P450 by Andrographis paniculata extract and andrographolide J Ethnopharmacol, advance online publication; doi: 10.1016/j.jep.2007.10.013
17. Jarukamjorn K, Don-in K, Makejaruskul C, Laha T, Daodee S, Pearaksa P et al. Impact of Andrographis paniculata crude extract on mouse hepatic cytochrome P450 enzymes.J Ethnopharmacol 2006; 105: 464-7
18. Donovan JL, DeVane CL, Chavin KD, Taylor RM, Mardowitz JS. Siberian ginseng (Eleutherococcus senticosus) effects on CYP2D6 and CYP3A4 activity in normal volunteers. Drug Metab Dispos 2003; 31: 519-22